Back to search results

Pilot Study: "Just ASK™" Training to Improve Breast Cancer Clinical Trial Discussions

This pilot study is testing a web-based training program called "Just ASK™." This program is designed to help oncology team members (doctors, nurses, and coordinators) understand how their assumptions might affect discussions about breast cancer clinical trials. The goal is to see if "Just ASK™" can increase the number of times these trials are discussed with all eligible breast cancer patients. Researchers want to find out if this type of study is practical and acceptable, what helps providers complete and use the training, and how discussion rates change after the training. They will also look at what parts of these discussions are linked to patients joining a trial. This study is for oncology team members at the Abramson Cancer Center in Philadelphia, PA, who routinely offer and enroll patients in breast cancer clinical trials. The study aims to enroll 80 participants, but its current status is unclear.

Study design
This is a pilot stepped-wedge cluster randomized controlled trial. It involves oncology team members and aims to enroll 80 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint, rates of discussion, will be measured at study completion, an estimated average of 1 year after recruitment ends.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07040891

A Pilot Trial of "Just ASK™" to Increase Discussions About Breast Cancer Clinical Trials

Recruiting
NAAges 18+InterventionalHealth services
Abramson Cancer Center at Penn Medicine
~80 participants
Updated 2026-04-23 on ClinicalTrials.gov
What's tested:Just ASK training

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Rates of discussion of breast cancer clinical trials
Measured over At the study completion (after all patient visit recordings are collected), an estimated average of 1 year after completion of recruitment.

Conditions

Breast Cancer

Explore related trials

Breast Carcinoma

Where it's being run

1 sites across 1 states
New Jersey1

Study leadership

  • Carmen E Guerra, MD · PRINCIPAL_INVESTIGATOR · University of Pennsylvania

Who to contact

Carmen Guerra, MD, MSCE
[email protected]
215-349-5374
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Members of teams of oncology (physicians, nurses/nurse practitioners and coordinators) who routinely offer, consent and enroll patients in breast cancer clinical trials at the Abramson Cancer Center, Philadelphia, PA
Able to provide informed consent.
Age \>18
Diagnosed with breast cancer and identified as potentially eligible for at least one breast cancer treatment clinical trial.
Evaluated at the Abramson Cancer Center by those oncology team members participating in this study.
Able to provide informed consent.

What this trial measures

  • Rates of discussion of breast cancer clinical trialsAt the study completion (after all patient visit recordings are collected), an estimated average of 1 year after completion of recruitment.

    Will measure differences in rates of discussion of clinical trials with breast cancer patients pre- and post-intervention (Just ASK training).